Evidence map›Paper›PMID 39192606›Full record

Observational studyCancer medicine2024

Factors associated with deferral or non-performance of an organized breast cancer screening program during the COVID-19 pandemic in France.

Jean Papadacci Stephanopoli, Leila Bouazzi, Myriam Guerbaz-Sommi, Olivier Graesslin, Aline Hurtaud, Salvatore Ilardo, Jan Chrusciel, Cécile Barbaret, Camille Bertrand, Stéphane Sanchez

Abstract readObservational Study
In one paragraph

Observational study in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jean Papadacci StephanopoliDepartment of General Medicine, Université de Reims Champagne-Ardenne, Reims, Marne, France.
Leila BouazziComité Universitaire de Ressources pour la Recherche en Santé,, Université de Reims Champagne-Ardenne, Reims, Marne, France.
Myriam Guerbaz-SommiCRCDC, Centre Régional de Coordination des Dépistages des Cancers du Grand Est, Troyes, Aube, France.
Olivier GraesslinDepartment of Gynecology and Obstetrics, Centre Hospitalier Universitaire de Reims, Université de Reims Champagne-Ardenne, Reims, Marne, France.
Aline HurtaudDepartment of General Medicine, Université de Reims Champagne-Ardenne, Reims, Marne, France.
Salvatore IlardoMédecine générale, Maison de Santé Pluriprofessionnelle de la Forêt d'Orient, Piney, Aube, France.
Jan ChruscielDepartment of Public Health and Performance, Centre Hospitalier de Troyes, Troyes, France.
Cécile BarbaretUniv. Grenoble Alpes, CNRS, CHU Grenoble Alpes, Grenoble Institute of Engineering, TIMC-IMAG,, Univ. Grenoble Alpes,, Grenoble, isère, France.ORCID 0000-0001-7144-7115
Camille BertrandCRCDC, Centre Régional de Coordination des Dépistages des Cancers du Grand Est, Troyes, Aube, France.
Stéphane SanchezComité Universitaire de Ressources pour la Recherche en Santé,, Université de Reims Champagne-Ardenne, Reims, Marne, France.ORCID 0000-0002-0925-6948

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelays in detection and treatment of breast cancer can lead to increased mortality. To date, participation in organized breast cancer screenings (OBCS) has been suboptimal worldwide. The objective of this study was to investigate the factors associated with deferral or non-performance of mammography during the COVID-19 pandemic for women who had previously participated in OBCS.

methodsA retrospective observational study was conducted on a cohort of 6282 women from the Aube Department of France, who were invited to an OBCS in 2020. Participants were divided into women who promptly underwent screening after receiving an invitation (between 22 and 25 months elapsed since the last mammogram), women who underwent late screening (≥26 months since the last mammogram), and those who were never screened. Data were collected from a self-reported questionnaire. Comparative and multivariable analyses modeling the probability of each type of attendance were performed using these data.

resultsIn total, 2301 women (aged 50-74 years) returned a valid questionnaire. Compared to women who promptly underwent mammography, non- and late-screening participants were younger, had less frequent gynecological follow-up and a less frequent history of colorectal cancer screening. Women with higher education status and those residing in socially disadvantaged areas were more likely to attend late.

conclusionThe absence of regular gynecological follow-up and the absence of colorectal cancer screening were significant factors associated with deferral of or non-attendance at OBCS.

Indexed as

Breast NeoplasmsEarly Detection of CancerMammographyAgedCOVID-19FemaleFranceHumansMass ScreeningMiddle AgedPandemicsRetrospective StudiesCOVID‐19healthcare promotionorganized programsscreeningscreeningbreast cancer

Identifiers

PMID39192606
PMCPMC11349821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.